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Angiotensin I converting enzyme and kinin—hydrolyzing enzymes along
the rabbit nephron. Angiotensin I converting enzyme (ACE) and
kininase activities were measured in various segments of the rabbit
nephron. ACE was determined with tritiated hippuryl-glycylglycine as
substrate. Lysyl-bradykinin (LBK) hydrolysis (kininase activity) was
measured by radioimmunoassay. ACE was only found in the
glomerulus and in the two parts of proximal tubule: the convoluted
proximal tubule and the pars recta (PR). It was distributed along a
concentration gradient which increased from the glomerulus to PR.
Kininase activity was found in both proximal and distal parts of the
nephron. Besides intense LBK-hydrolyzing activity in the proximal
tubule, a kininase activity was also found in the medullary collecting
tubule (MCT). Kininase activity in the glomerulus and the proximal
tubule was completely inhibited by chelating agents. Captopril inhibited
this activity only in the PR and at high concentrations (above iO- M).
These results indicate that several types of enzymes other than ACE
hydrolyze kinins in the glomerulus and in the proximal tubule. The
contribution of ACE to kinin hydrolysis appears only minimal. The
kininase activity found in MCT was different from ACE and other
proximal tubule kininases because it was not inhibited by chelating
agents. This kininase may play a physiological role in inactivating the
kinins formed by kallikrein at or beyond the connecting tubule.
Rapid kinin hydrolysis by the kidney is now well established
[1]. This hydrolysis is the consequence of the activity of several
types of peptidases, collectively called kininases. Although
most reports indicate that kinin hydrolysis mainly occurs in
proximal tubules [2], the results of stop—flow experiments
suggest the presence of kininase activity in the terminal part of
the nephron [3]. Among the kininases that may play a part in
kinin inactivation is kininase II. The latter enzyme has been
intensively studied, because, in addition to hydrolyzing kinins,
it converts angiotensin I to angiotensin II [4]. Kininase II,
generally referred as angiotensin I converting enzyme (ACE), is
the dipeptidyl-carboxypeptidase EC 3-4-15-1. It is also able to
hydrolyze in vitro several short—peptide substrates. In the
kidney, it is mainly localized in the brush—borders of the
proximal tubule cells [51. However, even if ACE is able to
hydrolyze kinins, its contribution to the renal inactivation
process of kinins is not clearly defined. Furthermore, since
urinary kinins are produced by kallikrein in the distal tubule [3],
it may be physiologically important to establish if kininase
activity is present in the late nephron segments. The present
study was therefore designed to investigate and quantify
kinin—hydrolyzing activity in the different portions of the neph-
ron and to explore the possible contribution of ACE to this
activity. For this purpose, we began by determining the distri-
bution of ACE along the microdissected rabbit nephron. This
was done by measuring hydrolysis of a tritiated ACE substrate.
The specificity of this measurement was established by studying
its inhibition by low doses of captopril. We also searched for
other kininase activities along the nephron by quantifying the
hydrolysis of lysyl—bradykinin. We then attempted to establish
whether or not the tubular kininase activity measured could be
inhibited by compounds capable of inactivating ACE, such as
chelating agents and captopril.
The results confirm the presence of both ACE and other
kininases in the proximal tubule, and demonstrate the occur-
rence of a concentration gradient for converting enzyme along
this segment. Kininase activity was also found in the terminal
part of the nephron, particularly in the medullary collecting
tubule. However, this activity is enterly due to an enzyme other
than ACE.
Methods
Biochemical materials
Collagenase (CLS, 146 U/mg) from Clostridium histolycum
was purchased from Worthington Biochemical Corp. (Free-
hold, New Jersey, USA). Deoxycholic acid, HEPES 4-(2-
hydroxyethyl) I -piperazine-ethanesulfonic acid and lysozyme
were from Sigma Chemical Co. (St. Louis, Missouri, USA);
ethylenediamine tetracetic acid disodium salt (EDTA), o-
phenanthroline hydrochloride and sodium sulfate came from
Merck (Darmstadt, FRG). Lysyl—bradykinin and hippuryl—
glycylglycine were from Bachem AG, Bubendorf, Switzerland.
CHAPS 3-[(3-cholamidopropyl) dimethyl-ammonioj-l-propane
sulfonate, was a product of Serva. Captopril was a gift from
Squibb (Paris, France). [H] hippuryl-glycylglycine (about 20
Ci/mmole) was synthetized and tritiated as previously described
[6].
Solutions
Received for publication April 29, 1986
and in revised form August 13, 1986
© 1987 by the International Society of Nephrology
The purfusion solution was a modified Hank's solution [7]
and contained in mM, 137 NaCI, 5 KCI, 0.8 MgSO4, 0.33 Na2
HPO4, 0.44 KH2PO4, 10 Tris-HC1 and 1 CaCI2, pH = 7.4.
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The microdissection medium was identical to the perfusion
medium except for CaCI2, whose concentration was 0.25 in-
stead of 1 mM.
Buffer 1(0.1 M sodium phosphate, pH = 7.0, containing 0.1%
lysozyme) was used for radioimmunoassay of bradykinin (BK).
Buffer!! consisted of 0.3 M Hepes, pH = 8.0, containing 0.3
M NaCI and 1.8 M Na2SO4 and was used to measure converting
enzyme activity.
Microdissection of tubules
Single nephron segments were isolated according to the
method described previously in detail [8]. Briefly, male New
Zealand rabbits weighing Ito 1.5 kg were anesthetized and bled
from the carotid artery. The left kidney was immediately
removed and infused with 20 ml of perfusion solution containing
0.1% collagenase and bovine serum albumin. Thin pyramids
were cut along the corticopapillary axis and incubated at 35°C
for 30 minutes in the presence of collagenase. After incubation,
the pyramids were rinsed with perfusion medium and kept on
ice.
Microdissection was performed by hand, in ice—cold solution
under stereomicroscopic observation. The glomeruli and dif-
ferent nephron segments were isolated and identified according
to the usual criteria [9]. These different segments were: the
convoluted part of proximal tubule (PCT) and its straight part
called pars recta (PR), the thin descending limb of Henle's loop
(TDL), the medullary and cortical segments of the thick ascend-
ing limb (MAL and CAL), the bright (DCTb) and granular
(DCTg) portions of the distal convoluted tubule, the cortical
medullary segments of the collecting tubule (CCT1 and MCT).
Each piece of tubule was transferred in microdissection
solution into a concave bacteriological glass slide, covered with
a second slide, and photographed to permit subsequent mea-
surement of its length.
Permeabilization and solubilization of tubules
Before measuring enzyme activities, the different nephron
segments were either permeabilized by an osmotic shock fol-
lowed by freezing and thawing, or solubilized by a detergent.
The osmotic shock was done by sucking out the excess of
microdissection medium and replacing it with 0.3 d of a
hypo-osmotic solution containing l0 M Tris-HCI, pH 8. This
step was performed under stereomicroscopic observation. Ad-
dition of the hypo-osmotic solution resulted in rapid swelling of
the cells, especially in the proximal tubule. The samples were
then frozen to —20°C and kept at this temperature overnight.
On the following day, the samples were thawed and refrozen a
second time before measurement. This procedure was adopted
after checking that the enzyme activities measured under these
conditions, that is after 18 hours storage, were not different
from those determined on the day of microdissection.
However, in case this permeabilization procedure was not
sufficient to allow full access of the substrate to all active
enzyme sites, additional measurements were carried out in
some experiments after solubilization of the tubule, This was
done by preincubating the samples for 30 minutes at 30°C with
either 0.5% deoxycholic acid or 3 mii CHAPS.
Micromethod for measurement of angiotensin I converting
enzyme activity in the tubule by hydrolysis of
hippuryl—glycylglycine
The micromethod used for measuring the activity of angio-
tensin I converting enzyme (ACE) was a miniaturized version
of Ryan's method [10]. This procedure measures the rate of
hydrolysis of the protected tritiated tripeptide [3H]-hip-
puryl—glycylglycine (3H-HGG) into glycylglycine and [3H]-l-
abeled hippurate. The hydrolysis is done at pH 8, in the
presence of unlabeled hippuryl—glycylglycine (HGG) and of
sulfate. In our experiments, the reaction proceeded in a final
volume of 3 d on the glass slide containing the tubule, which
had been permeabilized or solubilized as described above. Each
sample was adjusted to I l with l0 M Tris-HCI, pH =8. The
ACE reaction was started by adding 2 d of buffer II containing
30 nmoles HGG and 150,000 cpm 3H-HGG. The final concen-
tration of the substrate was 10 m (apparent ACE km = 5 mM)
[10] and its final specific activity was 5 sC/jsmol. After one or
two hours of incubation, the reaction was stopped by diluting
the medium with 50 d of 0.1 M HCI. The sample was then
transferred into a small glass tube and the slide was rinsed twice
with 50 l HCI. The volume in the tube was adjusted to 200 d.
The hippurate was extracted with 200 pi of ethyl acetate. The
aqueous and ethyl acetate phases were mixed by shaking for 30
seconds, and the layers were separated by centrifugation (1500
g for 10 mm). Forty sl of the ethyl acetate was transferred into
a small scintillation vial containing 3 ml of scintillation fluid and
counted for 10 minutes. To measure the specific radioactivity, 2
d of buffered substrate was directly added to five scintillation
vials.
In each experiment, five blank samples containing no tubule
were simultaneously treated with the experimental samples.
Under these conditions, less than 5% of substrate was parti-
tioned into ethyl acetate.
We checked that the reaction was inhibited by low concen-
trations of captopril (a potent inhibitor of ACE) [II] and by
chelating agents (since ACE is a metalloenzyme), in order to
insure that [3H]-HGG hydrolysis specifically reflected ACE
activity. The chelating agents were 1 mM EDTA and 1 mM
o-phenanthroline used together. Dose—response curves for
captopril were established on PCT and PR using concentrations
from 0.7. l0 M to 10—8 M. In each routine experiment, it was
systematically verified that the hydrolysis of HOG by each type
of segment studied was totally inhibited by l0 M captopril.
Converting enzyme activity was expressed as pmoles HOG
hydrolyzed per minute.
Micromethod for the measurenent of kininase activity in the
tubules by hydrolysis of' lysyl—bradykinin (LBK)
In preliminary experiments we checked that the urine kal-
likrein of rabbit releases LBK from kininogen (and not BK as in
the rat) [12]. LBK was therefore used to determine the kininase
activity in the different nephron segments. For the assay, 8.4
pmoles of LBK (in 0.7 d) were added to the glass slides
containing the permeabilized or deoxycholate—treated tubule.
Hydrolysis proceeded at 37°C in a final volume of 1.6 pi of 0.15
M Tris-HCI at pH 8 (LBK concentration = 5. 10—6 M). The
reaction was stopped after 15 or 30 minutes of incubation by
adding 50 p1 of buffer I containing l0 M EDTA and o-
746 Marcheui et a!
phenanthroline, and the sample was transferred into a Minisorp
tube. The slide was then rinsed twice with 50 jsl of buffer I.
which were added to the Minisorp tube. Each sample was
adjusted to one ml and kept frozen until the LBK was mea-
sured. This was done by radioimmunoassay using an antibody
which recognized BK and LBK but not fragments of BK [121.
In each experiment, five control samples containing LBK but
no tubule were run to check LBK stability during incubation.
The LBK recovery measured under these conditions was 86.2
1.2 (N 21).
To check the accuracy and reproducibility of the small
volume of LBK added in the enzymatic assay (0.7 'id), three
additional control samples were also run in each experiment.
They were prepared by directly adding LBK to Minisorp tubes.
The quantity of LBK measured in these control samples was
similar to the expected amount (8.64 0.23 pmoles, N = 21
experiments, vs. 8.40 pmoles). The interassay variability coef-
ficient calculated according to RODBARD [131, from the
SEM/mean x 100 ratio was therefore 2.6%.
To calculate kininase activity, the amount of LBK remaining
after incubation in the presence of tubule was subtracted from
the amount measured after incubation in the absence of tubule.
Kininase activity was expressed in picomoles of LBK hydro-
lyzed per minute and per millimeter of tubule.
Effect of chelating agents and captopril on kininase activit
The inhibition test was performed as follows: either 0.3 sl of
the EDTA plus o-phenanthroline mixture or 0.3 d of captopril
was added to the permeabilized or solubilized tubule. The
samples were then preincubated at 37°C for 10 minutes before
the addition of LBK. Separate controls containing the substrate
and chelators or captopril but not tubules were also run, to
check that these inhibitors did not interfere with LBK measure-
ments.
Checking of collagenase batches
As noted in the Microdissection of tubules section, the
isolation of nephron segments required collagenase treatment of
the kidney, which created a potential problem because the
commercial collagenase batches used were not pure. It was
therefore necessary to check that the impurities did not impair
the activity of ACE or of kininases. Since these enzymes are
known to be present in the brush border of proximal tubule cells
and in the glomerulus [14], the effect of collagenase was studied
on their activities. For this purpose, both kidneys of the same
rabbit were prepared: one, as usual, was infused with the
perfusion medium containing collagenase and serum albumin,
and the other was infused with Hank's solution only. The ACE
and kininase activities of microdissected glomeruli and portions
of proximal tubule from both kidneys were then measured.
We also checked that the perfusion medium was not able to
hydrolyze LBK by incubating 0.2 d of perfusion medium with
LBK under the usual conditions but in the absence of tubule.
After 30 minutes of incubation, LBK was measured.
Calculations
Except where otherwise indicated, results are expressed as
means SEM, and statistical analysis was performed using the
non-paired Student's (-test. The criterion for statistical signifi-
cance was taken as P < 0.05.
Results
Angiotensin I converting enzyme activity along the rabbit
nephron
Effect of collagenase on HGG hydrolysis. When tested in the
pars recta (PR), angiotensin I converting enzyme activity was
not affected by collagenase treatment (53.5 3.2
pmoles. min' mm, N = 7 samples from the collagenase
treated kidney vs. 52.7 1.8 pmoles . min' mm, N = 7
samples from the untreated kidney). When tested in the
glomerulus, ACE activity was barely detectable after such
treatment, but it became highly significant in the absence of
collagenase (0.65 0.06 pmoles . min' per glomerulus, N = 8,
vs. 2.16 0.21 pmoles• min1 per glomerulus, N = 8). Con-
sequently, the measurements were always performed on
glomeruli from kidneys not treated with collagenase.
Distribution of angiotensin I converting enzyme activity. The
hydrolysis of [3Hjhippuryl—glycylglycine (3H-HGG) by nephron
segments was considered to reflect ACE activity specifically
because it was completely inhibited by low concentrations of
captopril.
Only the glomerulus and the proximal tubule (PCT and PR)
were found to contain angiotensin I converting enzyme (ACE).
Figure 1 shows the ACE activities obtained when the samples
were permeabilized by osmotic shock and subsequent freezing
and thawing. ACE activity in the PR was four times higher than
that measured in the first mm of PCT (PCTa). The activity in
PCTb (that is, the fragment located 2.5 to 3 mm away from
PCTa) and in PCTC (the fragment located 1.5 to 2 mm away from
PCTb) doubled and tripled, respectively, as compared to that in
PCTa. ACE activity in the glomerulus was low compared to that
in the PR. Thus, if the amount of protein is assumed to be 75 ng
per glomerulus and 200 ng per mm of PR (15-8), it can be
calculated that the corresponding enzyme activities were 29
pmoles. min and 265 pmoles . min per g of protein in the
glomerulus and the PR, respectively.
The right part of Figure 1 shows the ACE activity in succes-
sive portions isolated from seven PCTS dissected over 7 mm or
more. This figure clearly indicates the existence of a converting
enzyme concentration gradient along proximal tubules.
No statistically significant level of ACE activity was mea-
sured in the other nephron segments (TDL: 0.57 0.55, CAL:
0.45 0.13, DCTb: 0.31 0.20, DCT5: 0 0, CCT1: 0.30
0.20, and MCT: 0.41 0,20 pmoles . mm .min).
ACE activity in the proximal tubule (PCT and PR) was also
measured after solubilization of these segments with either
0.5% deoxycholate or 3 mM CHAPS. After deoxycholate, the
ACE activity was three times less than in permeabilized tu-
bules. In spite of this reduction, an activity gradient was again
observed along all the proximal tubules (Table 1). In PR treated
with CHAPS, ACE activity was similar to that found in the
permeabilized PR (41.2 1.8, N = 8, vs. 42.6 2.5
pmoles• min' . mm, N = 7).
The effects of chelating agents and captopril on the activities
measured in the proximal tubule and in the glomerulus corre-
spond to the known properties of ACE: thus full inhibition was
induced by l0 M EDTA and o-phenanthroline and by io M
captopril.
As shown by the dose—response curves of Figure 2, the
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Fig. 1. Distribution of angiotensin I converting enzyme along the
proximal tubule. A. shows the converting enzyme activity measured in
the early, middle and late parts of the PCT, and in the PR. PCTa denotes
the first millimeter following the glomerulus. PCTb denotes the frag-
ments located 2.5 to 3 mm from PCTa. PCTC denotes the fragments
located 1.5 to 2mm from PCTb. For each fragment, 6—10 nephrons from
the same rabbit were tested. The number of rabbits studied is indicated
in the bars. B. shows the converting enzyme activity measured in
successive portions isolated from seven PCT, measuring over 7 mm
each. Each PCT was divided into 3 fragments (except for one, which
was divided into 4). The activity of each portion (ordinate) is expressed
in pmoles mm min' and plotted at the abscissa, which corresponds
to the distance between the glomerulus and the mid-point of the portion.
The values obtained for the same PCT are joined by lines.
activity measured in PCT and PR was highly sensitive to
captopril, since 1.7.l0 M caused 50% inhibition.
LBK hydrolyzing activity along the rabbit nephron
Effect of collagenase on LBK hydrolysis. The LBK-hydroly-
zing activity measured in glomeruli, PCT and PR from un-
treated and collagenase—treated kidneys of the same animal
showed that collagenase treatment did not significantly modify
that activity in the PCT or PR, but reduced it to some extent in
the glomeruli (Table 2).
In addition, when 8.4 pmoles of LBK was incubated in the
presence of 0.2 j.d of perfusion medium containing collagenase,
the amount LBK recovery after 30 minutes of incubation (mean
SD) was similar to that measured in control samples incubated
Segment Osmotic shock Deoxycholate
PCT, 17.1 1.2 (8) 4.7 0.5 (9)
PCTb 30.6 1.4 (8) 10.3 1.1 (8)
PCTC 52.3 3.2 (6) 14.0 1.7 (6)
PR 59.5 9.1 (6) 18.1 1.6 (6)
without collagenase (6.67 0.40 pmoles, N = 5 vs 6.99 0.29,
N=5).
Distribution of kininase activity along the rabbit nephron.
After an osmotic shock followed by two freezings and thawings,
glomeruli, early PCT and late PR hydrolyzed LBK at a fast rate:
after 15 minutes of incubation, 40% of LBK was hydrolyzed per
single glomerulus, and 47% per 0.5 mm of PCT or PR. Under
the same conditions, MCT hydrolyzed LBK only at low rate
which was not statistically significant. Therefore, the experi-
ments were repeated by incubating the inactive or poorly active
segments for 30 minutes with LBK. After that, a statistically
significant kininase activity was always measured in the MCT
(Fig. 3A). One millimeter of MCT hydrolyzed 2.8 pmoles of
LBK per 30 minutes, that is, 33% of the initial amount. When
the rate of LBK hydrolysis was correlated with the length of
tubule in the MCT samples incubated (Fig. 4), a linear relation-
ship was found (y = 2.58x — 0.17 and r = 0.843).
Kininase activity was also detected in the bright and granular
portions of the distal convoluted tubule (DCTb and DCTg) and
in the cortical collecting tubule (CCT1). However, it was not
statistically significant in any experiment. The mean percentage
of LBK hydrolyzed per mm after 30 minutes was 15% for
DCTb, 21% for DCTg and 20% CCT1.
Solubilizationwith deoxycholic acid did not significantly alter
LBK hydrolysis by the glomerulus, PCT or PR. In contrast, it
greatly reduced hydrolysis in the other segments, including
MCT (Fig. 3B).
Inhibition of LBK-hydrolyzing activities in the glomerulus,
PCT, PR and MCT by chelating agents and captopril
The LBK hydrolysis produced by the glomerulus, PCT and
PR was almost completely inhibited in the presence of 1 mri of
EDTA and o-phenanthroline. The inhibition occurred regard-
less of whether the tubules were treated by osmotic shock or
deoxycholic acid. In contrast, the hydrolysis of LBK was not
affected by these chelating agents in MCT, suggesting that
kininase activity was not due to the presence of a metal-
loenzyme in this nephron segment (Table 3).
As regards the captopril, tested at 5.106 M, it did not change
LBK hydrolysis in the glomerulus or PCT, and only partially
inhibited that of the PR (Fig. 5). When the tubules were
submitted to osmotic shock, this inhibition was 32.0 3.6%. It
was more marked when tubules were solubilized with
deoxycholic acid (48.3 5.1 P < 0.01). Figure 5 shows that
LBK hydrolyzing activity also decreased in MCT, but the
inhibition which averaged 29% was rather variable. Even when
tested at 5.10—i M, captopril remained ineffective in reducing
A Table 1. Effect of deoxycholate on angiotensin I converting enzyme
activity in the proximal tubule
50
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The fragments PCT, PCTb, PCTC are described in the legend to Fig.
1. Numbers in parenthesis denote the number of tubules.
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Table 2. Effect of collagenase on the kininase activity of glomeruli,
PCT and PR
Nephron Without With
segments collagenase collagenase
Glomeruli 2.77 0.27 (6) 1.84 0.35 (7)
PCT 8.66 0.91 (5) 7.59 1.02 (7)
PR 8.49 0.98 (5) 7.86 1.18 (7)
PR 7.04 1.91 (8)b 6.77 1,89 (g)b
a Kininase activity is expressed as picomoles of LBK hydrolyzed per
millimeter of tubule during 15 minutes of incubation. Values represent
mean SD. Numbers in parenthesis denote the number of tubules.
b The values without symbols represent the activity of glomeruli,
PCT and PR from the same rabbit. The values marked (b) were obtained
with PR from another rabbit during an additional experiment.
Fig. 2. Plot for the inhibition of angiotensin 1
converting enzyme activity in the PCT (A) and
PR (B) by captopril concentrations of 10 M
to 10-8 M. 0.7 sl of captopril was added to
the glass slides containing the permeabilized
tubule. The number of samples measured for
each concentration is indicated in the figures.
GI PCT PR TDL MAL CAL DCTb OCT9 CCT1 MCI
Fig. 3. Distribution of kininase activity along the rabbit nephron.
Before incubation, nephron segments were submitted either to an
osmotic shock followed by 2 freezings and thawings (A), or solubilized
by 0.5% deoxycholate (B). For each rabbit, 6—10 replicate samples per
nephron segment were tested. The number of rabbits studied is indi-
cated in the bars. All nephron segments could not be obtained from the
same experiment, but PCT or PR was studied in every case. *R < 0.05,
**D < 0.01, 'P < 0.001.
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the kininase activity of glomeruli and PCT (data not shown).
Finally, the dose—response curves established for the inhibition
by captopril of LBK hydrolysis in PR and MCT clearly indicate
it was more sensitive to captopril in PR than in MCT (Fig. 6).
Discussion
The present study shows that in the rabbit nephron, ACE and
other kininases are mainly present in the proximal tubule.
Whereas total kininase activity was similar along the entire
tubule, the ACE concentration gradually increases from
glomerulus to pars recta. A kinin—hydrolyzing activity was also
found in the terminal parts of nephron, particularly in the
medullary collecting tubule.
Collagenase treatment of the kidney is a procedure com-
monly used to permit microdissection of different nephron
segments. Without such treatment, it is very difficult to isolate
certain nephron segments. However, as collagenase contains
impurities which are liable to impair enzyme activity, we began
by testing segments, such as glomeruli or short fragments of
early PCT and PR, which could be dissected without it, and
compared the results to those obtained with collagenase—tre-
ated segments. We found that in the PCT and PR fragments,
collagenase treatment affected neither ACE nor kinin hydrolyz-
ing activity. However, in the glomerulus, it reduced both these
activities, particularly that of ACE, which became barely
detectable. This drastic reduction might be explained by the
fact that at least part of the activity measured in the glomerulus
originated from the endothelial cells of the vascular pole formed
5 5 6
by afferent and efferent arterioles, and that after collagenase
treatment, less of this vascular tissue was simultaneously
dissected with the glomerulus.
We noticed that the permeabilization of tubules by osmotic
shock plus freezing and thawing was the best procedure for
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Table 3. Effect of chelating agents on LBK hydrolysis in the glomerulus, PCT, PR and MCT
Glomerulus PCT PR MCT
Osmotic shock Control
EDTA + o-phenanthroline l03M
2.65 0.12 (7)
0.12 0.10(7)
6.35 0.36 (6)
0.15 0.11 (7)
10.10 0.69 (7)
0.21 0.15 (7)
2.63
2.98
0.09 (7)
0.20(7)
Deoxycholate Control
EDTA + o-phenanthroline l03M
2.86 0.22 (6)
0.39 0.20 (6)
9.37 1.30 (6)0 0(7) 10.97 0.70 (6)0.10 0.10(6)
—
—
0.3 d of a mixture of EDTA and o-phenanthroline prepared in 0.2 M Tris (pH = 8) was added to concave glass slides containing either a
permeabilized or solubilized tubule. LBK was added and the final concentration of EDTA and o-phenanthroline was 103M. The glomerulus, PCT
and PR were incubated for 15 minutes, and the MCT, for 30 minutes. Mean SEM, pmoles mm
6
C
E0
C
8)(0
0
>.
revealing the enzyme activities studied. However, to make sure
that this method enabled all the activity to be measured, we
compared the results to those obtained using detergents, since
ACE is known to be present in the brush—borders of proximal
tubule cells [15], a site which might be poorly accessible to the
substrate in isolated non-perfused tubules. However, solubili-
zation of nephron segments by deoxycholate did not reveal
more kininase activity in the glomerulus, PCT or PR than
osmotic shock plus freezing and thawing, and even inhibited the
kinin—hydrolyzing activity of MCT (Fig. 3). Deoxycholate also
inhibited ACE activity (Table I). Inhibition of enzyme activity
by deoxycholate has already been reported, and the use of a
less drastic detergent such as the zwitterion CHAPS has been
suggested [16]. In our experiments with CHAPS, the level of
ACE in the proximal tubule was neither decreased, nor in-
creased compared to that measured after permeabilization. This
latter observation indicates that the permeabilization procedure
we used allowed the ACE and LBK hydrolyzing activity in the
tubular cells to be fully revealed.
We showed that ACE is distributed in the proximal tubule
along a gradient which increased from the glomerulus to the
GI PCT PR MCT
100%
0
50%0
Captopril effect
Fig. 5. Effect of5,106 M captopril on the LBK hydrolysis produced by
the glomerulus, PCT, PR and MCT. 0.3 d of captopril in 0.2 M TRIS
pH 8 was added to the samples containing the permeabilized or
solubilized tubules. Slides were then preincubated for 10 mm before
addition of LBK. The final concentration of captopril was 5.106 M. The
glomerulus, PCT and PR samples were incubated for 15 mm, whereas
the MCT samples were incubated for 30 mm. For each rabbit and each
experimental condition, 6—8 samples of the same segment were tested.
Number of rabbits is indicated in bars, () osmolic shock, (Z) deoxy-
cholate. Results are expressed as the percentage of the mean control
kininase activity measured in the same experiment, in the absence of
captopril.
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Fig. 4. MCT length dependency of LBK hydrolysis. MCT of different
lengths were incubated for 30 mm. at 37°C with 8.4 pmoles of LBK.
Abscissa, mm of tubule; ordinate, pmoles of LBK hydrolyzed in 30
mm. r = 0.843; y = 2.58x — 0.17.
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Fig. 6. Plot of percent inhibition of kininase activity in PR (A) and
MCT (B) by captopril concentrations ranging from IO M to io— M.
The experiment was performed as described in the legend to Fig. 5, by
adding 0.3 sl of increasing concentrations of captopril. PR were
previously solubilized by deoxycholate and MCT were permeabilized
by osmotic shock and freezing and thawing. The number of samples
studied for each concentration is indicated on the curves.
pars recta. The highest level of activity was found in the PR.
This observation agrees with the results of Sudo for the rat
nephron [15]. Like Ward et al [14], we also found low ACE
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activity in the glomerulus. None at all was measured in the
descending and ascending limbs, the two portions of distal
convoluted tubule or in the collecting tubule, although im-
munofluorescence test suggested that it may also be present in
the distal tubule of species other than the rabbit [17].
The ACE activity found here in the glomerulus, PCT and PR
was completely inhibited by chelating agents, and was inhibited
by captopril to a similar degree in the PCT and PR (Fig. 2)
which demonstrate that the same enzyme activity was mea-
sured in the PCT and PR. In addition, the characteristics of
captopril inhibition for ACE in PCT and PR were very similar to
those reported for ACE in intestinal and vascular surface
membrane [18] and to those which we found with a purified
ACE preparation from human kidney (data not shown).
As previously observed by micropunctures of rat nephron
[1], kinins are very quickly hydrolyzed by the proximal tubule.
A similar rate was found here for LBK hydrolysis at the
beginning and end of the proximal tubule (PCT and PR). This
hydrolysis was completely inhibited by EDTA and o-
phenanthroline in both segments. Captopril, however, affected
each one differently: it inhibited kinin—hydrolyzing activity in
PR only, but it did not affect the activity of the early PCT, even
at a concentration of 5.iO5 M. Captopril also failed to inhibit
kininase activity in the glomerulus. Consequently, kinin hydrol-
ysis in the glomerulus, PCT and PR must involve different
enzymes. The fact that captopril had no inhibitory effect in the
glomerulus or PCT indicates that ACE, although present, does
not contribute to LBK hydrolysis in these parts. In the pars
recta, the inhibition of kinin—hydrolyzing activity was total
when the captopril concentration was high (5.10—a M, Fig. 4).
This concentration was higher than that required to inhibit the
LBK-hydrolyzing activity of a purified ACE preparation from
human kidney, measured under our experimental conditions,
since half the activity of this preparation was inhibited by a
captopril concentration of only l0— M, and complete inhibition
was obtained with 10-6 M (results not shown). These concen-
trations were respectively 50 and 500 times lower than those
required to inhibit by 50% and 100% the LBK-hydrolyzing
activity of the pars recta (Fig. 6). It is, therefore, very likely that
at the high concentrations used here to inhibit this activity in the
pars recta, captopril simultaneously inhibited ACE and the
other kininases present. Although, our results do not allow
quantification of the contribution of ACE to kinin hydrolysis in
pars recta, it cannot be very high despite the fact that this
segment contained a large amount of ACE.
The physiological significance of the ACE concentration
gradient we found here in the proximal tubule remains unex-
plained, and the role of ACE in the kidney has not in fact been
well defined as yet in either the renin angiotensin or kallikrein
kinin systems. Its localization in the proximal tubule does not
allow its involvement in the inactivation of kinins generated by
the kidney. The characteristics of the intrarenal kallikrein—kinin
system (localization of kallikrein in the connecting tubule and of
kininogen in the collecting duct system) [19—23] rather involve
the terminal parts of nephron. However, ACE is presumably
involved in the intrarenal formation of angiotensin II, which
might control sodium reabsorption in the proximal tubule [24]
by acting not only on the peritubular side but also on the luminal
side [25—271.
One original observation of the present study is the presence
of kininase activity in the MCT. This activity was not due to
ACE, since it was not inhibited by EDTA and o-phenanthro-
line, and was little affected by captopril, even at high concen-
trations such as 5.l0- M (Table 3 and Figs. 5, 6). The absence
of inhibition by chelating agents also indicates that kininase
activity in the MCT may not be due to the presence of
enkephalinase A (NEP), an enzyme which, however, highly
contributes to the degradation of bradykinin in the urine [281.
The nature of the kininase present in MCT remains unknown,
but its activity might resemble the type of kinin—hydrolyzing
activity which is insensitive to EDTA and was observed by
Cicclini et al [291 in the soluble fraction of rabbit kidney
homogenate. In the literature, divergences subsist as regards
the presence of kininase activity in the terminal parts of the
nephron. On the one hand, Carone et al [1] did not find any
inactivation of bradykinin after its injection into the distal part
of the rat nephron. On the other, Scicli, Gandolfi and Carretero
[3] used the stop flow technique to determine the site of
formation of kinins and found evidence for some kininase
activity in the terminal segments. The differences between
these results might be due to the low level of kininase activity
observed.
The presence of kininase in the MCT might be physiologically
important because this segment is a target site for the action of
kinin, as demonstrated by the existence of bradykinin receptors
along the CCT and MCT [30]. At the present time, we can only
speculate on the physiological function of this enzyme in MCT
because it is not known now if it is localized on the cell
membrane and/or intracellularly. However, because this kinin-
ase activity is located in the terminal parts of the nephron, it
may be involved in the hydrolysis of the kinins formed by the
kidney, at and/or beyond its production site in the connecting
tubule [19—23]. Partial inactivation of kinins by the terminal part
of the nephron might explain, at least in part, the difficulty of
correlating urinary kallikrein activity and kinin excretion F3 1].
Studies designed to determine the nature and function of this
kininase activity are now in progress.
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